These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 33433192)
21. Stimuli Responsive, Programmable DNA Nanodevices for Biomedical Applications. Singh U; Morya V; Datta B; Ghoroi C; Bhatia D Front Chem; 2021; 9():704234. PubMed ID: 34277571 [TBL] [Abstract][Full Text] [Related]
22. DNA nanotechnology-based development of delivery systems for bioactive compounds. Mohri K; Nishikawa M; Takahashi Y; Takakura Y Eur J Pharm Sci; 2014 Jul; 58():26-33. PubMed ID: 24694593 [TBL] [Abstract][Full Text] [Related]
23. DNA Nanostructures as Programmable Biomolecular Scaffolds. Yang YR; Liu Y; Yan H Bioconjug Chem; 2015 Aug; 26(8):1381-95. PubMed ID: 25961418 [TBL] [Abstract][Full Text] [Related]
25. DNA Nanodevices: From Mechanical Motions to Biomedical Applications. Wang Y; Wang Z; Wu X; Liu S; Liu F; Jiang Q; Ding B Curr Top Med Chem; 2022; 22(8):640-651. PubMed ID: 34749612 [TBL] [Abstract][Full Text] [Related]
26. Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system. Silva GA Ann N Y Acad Sci; 2010 Jun; 1199():221-30. PubMed ID: 20633128 [TBL] [Abstract][Full Text] [Related]
27. Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology. Polizu S; Savadogo O; Poulin P; Yahia L J Nanosci Nanotechnol; 2006 Jul; 6(7):1883-904. PubMed ID: 17025102 [TBL] [Abstract][Full Text] [Related]
28. DNA Nanostructures: Current Challenges and Opportunities for Cellular Delivery. Lacroix A; Sleiman HF ACS Nano; 2021 Mar; 15(3):3631-3645. PubMed ID: 33635620 [TBL] [Abstract][Full Text] [Related]
29. Neural interfaces at the nanoscale. Pancrazio JJ Nanomedicine (Lond); 2008 Dec; 3(6):823-30. PubMed ID: 19025456 [TBL] [Abstract][Full Text] [Related]
30. Structural DNA Nanotechnology: Artificial Nanostructures for Biomedical Research. Ke Y; Castro C; Choi JH Annu Rev Biomed Eng; 2018 Jun; 20():375-401. PubMed ID: 29618223 [TBL] [Abstract][Full Text] [Related]
31. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders. Hassanzadeh P; Atyabi F; Dinarvand R Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367 [TBL] [Abstract][Full Text] [Related]
32. Precisely Tailored DNA Nanostructures and their Theranostic Applications. Zhu B; Wang L; Li J; Fan C Chem Rec; 2017 Dec; 17(12):1213-1230. PubMed ID: 28608630 [TBL] [Abstract][Full Text] [Related]
33. Polysaccharide-Based Nanobiomaterials as Controlled Release Systems for Tissue Engineering Applications. Rodriguez-Velazquez E; Alatorre-Meda M; Mano JF Curr Pharm Des; 2015; 21(33):4837-50. PubMed ID: 26290209 [TBL] [Abstract][Full Text] [Related]
34. Dynamic DNA nanostructures in biomedicine: Beauty, utility and limits. Jahanban-Esfahlan A; Seidi K; Jaymand M; Schmidt TL; Majdi H; Javaheri T; Jahanban-Esfahlan R; Zare P J Control Release; 2019 Dec; 315():166-185. PubMed ID: 31669209 [TBL] [Abstract][Full Text] [Related]
35. Advanced polymeric nanotechnology to augment therapeutic delivery and disease diagnosis. Martins C; Chauhan VM; Araújo M; Abouselo A; Barrias CC; Aylott JW; Sarmento B Nanomedicine (Lond); 2020 Aug; 15(23):2287-2309. PubMed ID: 32945230 [TBL] [Abstract][Full Text] [Related]
36. Engineering DNA Nanostructures to Manipulate Immune Receptor Signaling and Immune Cell Fates. Tseng CY; Wang WX; Douglas TR; Chou LYT Adv Healthc Mater; 2022 Feb; 11(4):e2101844. PubMed ID: 34716686 [TBL] [Abstract][Full Text] [Related]
37. On the nature of biomaterials. Williams DF Biomaterials; 2009 Oct; 30(30):5897-909. PubMed ID: 19651435 [TBL] [Abstract][Full Text] [Related]
38. Potential of Natural Biomaterials in Nano-scale Drug Delivery. Houacine C; Yousaf SS; Khan I; Khurana RK; Singh KK Curr Pharm Des; 2018; 24(43):5188-5206. PubMed ID: 30657035 [TBL] [Abstract][Full Text] [Related]
39. Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems. Caldorera-Moore M; Peppas NA Adv Drug Deliv Rev; 2009 Dec; 61(15):1391-401. PubMed ID: 19758574 [TBL] [Abstract][Full Text] [Related]